Faldaprevir, pegylated interferon, and ribavirin for treatment-naïve HCV genotype-1: pooled analysis of two phase 3 trials-Reference-Cited by-同舟云学术

Faldaprevir, pegylated interferon, and ribavirin for treatment-naïve HCV genotype-1: pooled analysis of two phase 3 trials

Published:2016-05 Issue:3 Volume:15 Page:333-349
ISSN:1665-2681
Container-title:Annals of Hepatology
language:en
Short-container-title:Annals of Hepatology

Author:

Jensen Donald M.,Asselah Tarik,Dieterich Douglas,Foster Graham R.,Sulkowski Mark S.,Zeuzem Stefan,Mantry Parvez,Yoshida Eric M.,Moreno Christophe,Ouzan Denis,Wright Mark,Morano Luis E.,Buynak Robert,Bourlière Marc,Hassanein Tarek,Nishiguchi Shuhei,Kao Jia-Horng,Omata Masao,Paik Seung W.,Wong David K.,Tam Edward,Kaita Kelly,Feinman S. Victor,Stern Jerry O.,Scherer Joseph,Quinson Anne-Marie,Voss Florian,Gallivan John-Paul,Böcher Wulf O.,Ferenci Peter

Publisher

Elsevier BV

Subject

Hepatology,General Medicine

Link

http://publisherspanel.com/icid/pdf/1198803

Reference32 articles.

1. Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence.;Mohd Hanafiah;Hepatology,2013

2. World Health Organization. Hepatitis C. Fact sheet number 164. Updated April 2014. Available from: http://www.who. int/mediacentre/factsheets/fs164/en/.

3. 2011 European Association of the Study of the Liver hepatitis C virus clinical practice guidelines.;Liver Int,2012

4. Expert opinion on the treatment of patients with chronic hepatitis C.;Zeuzem;J Viral Hepat,2009

5. Peginterferon-alpha2a and rib-avirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose.;Hadziyannis;Ann Intern Med,2004

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evolution of HCV NS3/4a Protease Inhibitors;Topics in Medicinal Chemistry;2019